Enhanced Intercellular Retention Activity of Novel pH-sensitive Polymeric Micelles in Wild and Multidrug Resistant MCF-7 Cells
- 514 Downloads
The purpose of this work was to demonstrate the advantage of using pH-sensitive polymeric mixed micelles (PHSM) composed of poly(l-histidine) (polyHis)/poly(ethylene glycol) (PEG) and poly(l-lactic acid) (pLLA)/PEG block copolymers with folate conjugation to increase drug retention in wild-type and MDR tumor cells.
Materials and Methods
Both wild-type and multidrug resistant (MDR) human breast adenocarcinoma (MCF-7) cell lines were used to investigate the accumulation and elimination of doxorubicin (DOX), PHSM with folate (PHSM/f), and pH-insensitive micelles composed of pLLA/PEG block copolymer with folate (PHIM/f).
Cells treated with PHSM/f showed decelerated elimination kinetics compared to cells treated with PHIM/f. MDR cells treated with drug-containing PHSM/f for 30 min retained 80% of doxorubicin (DOX) even after incubation for 24 h in the absence of drug. On the other hand, cells treated with drug-containing PHIM/f retained only 40% of DOX within the same period of time. Flow cytometry and confocal microscopy confirmed these results.
Cellular entry of the micelles occurred via receptor-mediated endocytosis using folate receptors. The pH-induced destabilization of PHSM/f led to rapid distribution of drug and polymer throughout the cells, most likely due to polyHis-mediated endosomal disruption. This reduced the likelihood of drug efflux via exocytosis from resistant tumor cells.
Key wordsexocytosis folate multidrug resistance pH-sensitive polymeric micelle poly(l-histidine)
The authors would like to thank Deepa Mishra (University of Utah) for carefully editing the English in this manuscript. This work was supported by NIH CA101850.
- 4.A. M. Cataldo, S. Petanceska, C. M. Peterhoff, N. B. Terio, C. J. Epstein, A. Villar, E. J. Carlson, M. Staufenbiel, and R. A. Nixon. App gene dosage modulates endosomal abnormalities of Alzheimer’s disease in a segmental trisomy 16 mouse model of down syndrome. J. Neurosci. 23:6788–6792 (2003).PubMedGoogle Scholar
- 9.J. H. Hooijberg, G. J. Peters, Y. G. Assaraf, I. Kathmann, D. G. Priest, M. A. Bunni, A. J. Veerman, G. L. Scheffer, G. J. Kaspers, and G. Jansen. The role of multidrug resistance proteins MRP1, MRP2 and MRP3 in cellular folate homeostasis. Biochem. Pharmacol. 65:765–771 (2003).PubMedCrossRefGoogle Scholar
- 12.E. Aronica, J. A. Gorter, G. H. Jansen, C. W. van Veelen, P. C. van Rijen, S. Leenstra, M. Ramkema, G. L. Scheffer, R. J. Scheper, and D. Troost. Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors. Neuroscience. 118:417–429 (2003).PubMedCrossRefGoogle Scholar
- 13.Y. G. Assaraf, L. Rothem, J. H. Hooijberg, M. Stark, I. Ifergan, I. Kathmann, B. A. C. Dijkmans, G. J. Peters, and G. Jansen. Loss of multidrug resistance protein 1 expression and folate efflux activity results in a highly concentrative folate transport in human leukemia cells. J. Biol. Chem. 278:6680–6686 (2003).PubMedCrossRefGoogle Scholar
- 18.J. S. Park, T. H. Han, K. Y. Lee, S. S. Han, J. J. Hwang, D. H. Moon, S. Y. Kim, and Y. W. Cho. N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: Endocytosis, exocytosis and drug release. J. Control. Release 115:37–45 (2006).PubMedCrossRefGoogle Scholar
- 20.J. A. Reddy and P. S. Low. Folate-mediated targeting of therapeutic and imaging agents to cancers. Crit. Rev. Ther. Drug Carr. Syst. 15:587–627 (1998).Google Scholar
- 22.M. Stark, L. Rothem, G. Jansen, G. L. Scheffer, I. D. Goldman, and Y. G. Assaraf. Antifolate resistance associated with loss of MRP1 expression and function in Chinese Hamster ovary cells with markedly impaired export of folate and cholate. Mol. Pharmacol. 64:220–227 (2003).PubMedCrossRefGoogle Scholar
- 30.N. Oku, N. Yamaguchi, N. Yamaguchi, S. Shibamoto, F. Ito, and M. Nango. The fusogenic effect of synthetic polycations on negatively charged lipid bilayers. J. Biochem. (Tokyo) 100:935–944 (1986).Google Scholar
- 33.L. D. Skarsgard, D. K. Acheson, A. Vinczan, B. C. Wouters, B. E. Heinrichs, D. W. Loblaw, A. I. Minchinton, and D. J. Chaplin. Cytotoxic effect of RB 6145 in human tumour cell lines: dependence on hypoxia, extra- and intracellular pH and drug accumulation. Br. J. Cancer. 72:1479–1486 (1995).PubMedGoogle Scholar
- 40.K. Kataoka, T. Matsumoto, M. Yokoyama, T. Okano, Y. Sakurai, S. Fukushima, K. Okamoto, and G. S. Kwon. Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J. Control. Release 64:143–153 (2000).PubMedCrossRefGoogle Scholar